S-1 1 ds1.htm DEKANIA CORP--FORM S-1 REGISTRATION STATEMENT Dekania Corp--Form S-1 Registration Statement
Table of Contents

As filed with the Securities and Exchange Commission on June 6, 2006

Registration No. 333-            


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

DEKANIA CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

6770

(Primary Standard Industrial Classification Code Number)

 

84-1703721

(I.R.S. Employer Identification Number)

 

2929 Arch Street, Suite 1703

Philadelphia, Pennsylvania 19104

(215) 701-9555

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Thomas Friedberg, President

Dekania Corp.

2929 Arch Street, Suite 1703

Philadelphia, Pennsylvania 19104

(215) 701-9555

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

J. Baur Whittlesey, Esq.

Julie H. Bekier, Esq.

Mark E. Rosenstein, Esq.

Ledgewood, P.C.

1900 Market Street, Suite 750

Philadelphia, PA 19103

(215) 731-9450

(215) 735-2513—Facsimile

 

Douglas S. Ellenoff, Esq.

Lawrence A. Rosenbloom, Esq.

Ellenoff Grossman & Schole LLP

370 Lexington Avenue

New York, New York 10017

(212) 370-1300

(212) 370-7889—Facsimile

 

Jack I. Kantrowitz, Esq.

Sidley Austin LLP

787 Seventh Avenue

New York, NY 10019

(212) 839-5300

(212) 839-5599—Facsimile

 

Approximate date of commencement of proposed sale to the public:  As soon as practicable after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box:  x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:  ¨

 

CALCULATION OF REGISTRATION FEE

                         
Title of Each Class of
Security Being Registered
  Amount
Being
Registered
  Maximum
Offering Price
Per Security
  Proposed
Maximum
Aggregate
Offering Price(1)
  Amount of
Registration Fee
 

Units, each consisting of one share of Common Stock, $0.0001 par value, and one Warrant(2)

  11,155,000   $ 10.00   $ 111,550,000   $ 11,936  

Shares of Common Stock included as part of the Units(2)

  11,155,000     —       —       —   (3)

Warrants included as part of the Units(2)

  11,155,000     —       —       —   (3)

Shares of Common Stock underlying the Warrants included in the Units(4)

  11,155,000   $ 8.00   $ 89,240,000   $ 9,549  

Total

            $ 200,790,000   $ 21,485 (5)
                         
(1)   Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o).
(2)   Includes 1,455,000 units, consisting of 1,455,000 shares of common stock and 1,455,000 warrants, which may be issued upon exercise of a 45-day option granted to the underwriters to cover overallotments, if any.
(3)   No fee pursuant to Rule 457(g).
(4)   Pursuant to Rule 416, there are also being registered such indeterminable additional securities as may be issued to prevent dilution as a result of stock splits, stock dividends or similar transactions.
(5)   Paid herewith.

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 



Table of Contents

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

Subject to Completion

Preliminary Prospectus dated June 6, 2006

 

PROSPECTUS

 

$97,000,000

 

DEKANIA CORP.

 

9,700,000 Units

 


 

Dekania Corp. is a newly organized Business Combination Company™, or BCC™. A BCC™ is a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition or other similar business combination, one or more unidentified businesses. We intend to focus on identifying prospective targets in the insurance industry in the United States, Canada, Bermuda and the Cayman Islands. We do not have any specific merger, capital stock exchange, asset acquisition or other similar business combination under consideration and we have not contacted any prospective target business or had any discussion, formal or otherwise, with respect to such a transaction.

 

This is the initial public offering of our securities. We are selling 9,700,000 units. Each unit is being sold at a purchase price of $10.00 per unit and consists of:

 

  Ÿ   one share of our common stock; and

 

  Ÿ   one warrant.

 

Each warrant entitles the holder to purchase one share of our common stock at an exercise price of $8.00. Each warrant will become exercisable on the later of our consummation of an initial business combination or [                    ], 2007 [the first anniversary of the date of this prospectus], and will expire on [                    ], 2010 [the fourth anniversary of the date of this prospectus], or earlier upon redemption.

 

Our sponsor is Cohen Bros. Acquisitions, LLC, one of our initial stockholders, which we refer to as our Sponsor, a wholly-owned subsidiary of Cohen Brothers, LLC. Cohen Brothers, LLC is a diversified financial company that structures financing to banks and insurance companies through issuances of collateralized debt obligations, or CDOs. Cohen Brothers, LLC, through its subsidiaries, manages CDOs that hold trust preferred and similar fixed income securities issued primarily by banks, insurers and their holding companies. Subsidiaries of Cohen Brothers, LLC currently manage approximately $2 billion of insurance company debt securities held in CDOs. Due to its regular interactions and contacts in the insurance industry, we believe that our Sponsor is positioned to assist us in pursuing a business combination in the insurance industry.

 

Our Sponsor has agreed to purchase an aggregate of 250,000 units from us in a private placement which will close no less than two days before the effectiveness of the registration statement of which this prospectus is a part. The total purchase price for the units will be $2,500,000 or $10.00 per unit. No underwriting discounts and commissions or placement fees will be payable in connection with the private placement. The shares and warrants comprising the units sold in the private placement may not be sold, assigned or transferred by our Sponsor until after we have consummated a business combination. Our Sponsor will have no right to any liquidation distributions with respect to the shares included in such private placement units in the event we fail to consummate a business combination.

 

We have granted the underwriters a 45-day option to purchase up to an additional 1,455,000 units, solely to cover overallotments, if any. The overallotment option will be used only to cover any net syndicate short position that may result from the initial distribution.

 

There is presently no public market for our units, common stock or warrants. We intend to apply to have the units listed on the American Stock Exchange under the symbol              and, once the common stock and warrants comprising the units begin separate trading, to have them listed under the symbols              and             , respectively.

 

Investing in our securities involves risks that are described in the “ Risk Factors” section beginning on page 16 of this prospectus.


Table of Contents

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 


 

     Per Unit

   Total(1)

Public offering price

   $10.00    $97,000,000

Underwriting discounts and commissions(2)

   $.50    $4,850,000

Proceeds, before expenses, to Dekania Corp.

   $9.50    $92,150,000
(1)   The underwriters have an option to purchase an additional 1,455,000 units from us at the public offering price, less the underwriting discount and commission, within 45 days of the date of this prospectus to cover any overallotments. If the underwriters exercise this option in full, the total public offering price, underwriting discounts and commissions and proceeds, before expenses, to us, will be $111,550,000, $5,141,000 and $106,409,000, respectively.
(2)   Does not include deferred underwriting compensation in the amount of 2% of the gross proceeds, or $0.20 per unit, an aggregate of $1,940,000 (and 4% of the gross proceeds of the underwriters’ overallotment option, or $0.40 per unit, an aggregate of $2,522,000 if the overallotment option is exercised in full), which will be deposited in the Trust Account, referred to below, and become payable to the underwriters only upon completion of a business combination and then only with respect to those units as to which the component shares have not been redeemed. The deferred underwriting compensation will be forfeited if we do not complete a business combination.

 

If we do not complete a business combination within the time periods specified in this prospectus, we must liquidate and return to investors in this offering or their successors, which we refer to as the public stockholders, not less than $10.00 per share of common stock held by them. To fund this obligation, we have established a trust account, which we refer to as the Trust Account, at Deutsche Bank Trust Company Americas for which our transfer agent, American Stock Transfer & Trust Company, will act as trustee. The Trust Account will at all times have at least $97,000,000 ($111,550,000 if the overallotment option is exercised in full), or $10.00 per unit, of available funds. We will establish this availability by:

 

  Ÿ   Depositing the proceeds of this offering and the private placement, net of underwriting discounts and commissions and offering expenses and $40,000 to fund working capital, but including deferred underwriting compensation, into the Trust Account ($94,000,000; $108,259,000 if the overallotment option is exercised in full).

 

  Ÿ   Delivering a letter of credit from our Sponsor to American Stock Transfer & Trust Company for the benefit of the public stockholders and the Trust Account in the amount of $3,000,000 ($3,291,000 if the overallotment option is exercised in full).

 

If we do not complete a business combination within the time periods specified in this prospectus, we will implement a stockholder approved plan of dissolution and liquidation and the funds in the Trust Account will be distributed to our public stockholders, in each case as set forth in this prospectus. To the extent that funds in the Trust Account are insufficient to provide public stockholders with a distribution of $10.00 per share, funds will be drawn from the letter of credit. Interest earned on the funds in the Trust Account, after payment of up to $2,500,000 to cover our administrative expenses, working capital, expenses in seeking business combinations or implementing a plan of dissolution and liquidation, if necessary, and reduction of the principal amount of the letter of credit, will be allocated pro rata among the shares held by the public stockholders.

 

Shares acquired by our Sponsor and our officers and directors in connection with our formation and as components of units to be acquired by our Sponsor in the private placement will not be entitled to liquidation distributions from the Trust Account. However, our Sponsor and our officers and directors will participate in the liquidation distributions to the extent of any shares they have acquired in this offering or in the secondary market.

 

The units will be ready for delivery on or about                     , 2006.

 


 

Merrill Lynch & Co.

Maxim Group LLC

 


 

The date of this prospectus is                     , 2006.


Table of Contents

TABLE OF CONTENTS

 

Summary

   1

Summary Financial Data

   15

Risk Factors

   16

Special Note About Forward-Looking Statements

   40

Use of Proceeds

   41

Dilution

   45

Capitalization

   47

Dividend Policy

   47

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   48

Proposed Business

   50

Management

   69

Principal Stockholders

   74

Certain Relationships and Related Transactions

   75

Description of Securities

   77

Underwriting

   83

Legal Matters

   88

Experts

   88

Where You Can Find Additional Information

   88

Index to Financial Statements

   F-1

 


 

You should rely only on the information contained in this prospectus. We have not, and the underwriters have not, authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the underwriters are not, making an offer of these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operation and prospects may have changed since that date.

 

We obtained statistical data, market data and other industry data and forecasts used throughout this prospectus from publicly available information. While we believe that the statistical data, industry data, forecasts and market research are reliable, we have not independently verified the data, and we do not make any representation as to the accuracy of the information.

 

“Business Combination Company” and “BCC” are service marks of Maxim Group LLC.


Table of Contents

SUMMARY

 

This summary highlights information appearing elsewhere in this prospectus. For a more complete understanding of this offering, you should read the entire prospectus carefully, including the section entitled “Risk Factors,” our financial statements and the related notes to the financial statements, before making an investment decision.

 

Unless otherwise stated in this prospectus, references to “we,” “us,” “our” or the “company” refer to Dekania Corp., and the term “public stockholders” means only the holders of the 9,700,000 shares (11,155,000 shares if the overallotment option is exercised in full) of common stock sold as part of the units in this offering or acquired in the secondary market; it excludes our Sponsor and our officers and directors with respect to the shares they acquired upon our formation and our Sponsor with respect to the shares included in the units purchased by it in the private placement which will be completed immediately before the completion of this offering, but includes any shares they purchase in this offering or in the open market. Unless we tell you otherwise, the information in this prospectus assumes that the underwriters have not exercised their overallotment option.

 

The term “business combination” as used in this prospectus means a merger, capital stock exchange, asset acquisition, capital investment, stock purchase or other similar transaction with one or more target businesses.

 

The term “target business” as used in this prospectus includes one or more operating businesses in the insurance industry in the United States, Canada, Bermuda or the Cayman Islands.

 

The term “Trust Account” as used in this prospectus means the trust account established at Deutsche Bank Trust Company Americas, for which American Stock Transfer & Trust Company will act as trustee, to hold net proceeds of this offering, proceeds of the private placement to our Sponsor, the deferred underwriting discount and commission, the net interest (after taxes payable) thereon and the proceeds of any draws on the letter of credit furnished by our Sponsor, pending a business combination.

 

Our Company

 

We are a recently organized blank check company known as a Business Combination Company, or BCC. We were incorporated under Delaware law on February 28, 2006 for the purpose of acquiring one or more businesses through a business combination. We intend to focus our efforts on identifying businesses within the insurance industry in United States, Canada, Bermuda and the Cayman Islands, with particular interest in businesses that provide insurance coverage for uncommon or hard-to-place risks, an area known as specialty insurance. We expect that any target business that is incorporated in Canada, Bermuda or the Cayman Islands will have substantially all of its business, and all of its insurance risk, in the United States. We have not identified or begun discussions with any target business. Moreover, we have not engaged or retained any agent or other representative to identify or locate any suitable target business.

 

Our initial business combination must be with one or more target businesses whose fair market value is at least equal to 80% of the amount in the Trust Account, net of amounts for taxes, the underwriters’ deferred compensation amount and up to $2,500,000 for working capital needs, and excluding the letter of credit amount. We currently have no restrictions on our ability to seek additional funds through the sale of securities or through loans. As a consequence, we could seek to acquire a target business that has a fair market value significantly in excess of 80% of the net amount in the Trust Account and could seek to fund the business combination through the sale of our securities or through loans. However, if we were to seek additional financing, such financing will be made only in connection with the consummation of a business combination.

 

1


Table of Contents

If we elect to pursue the simultaneous acquisitions of several assets or operating businesses at the same time, we could encounter difficulties in consummating all or a portion of such acquisitions due to a lack of adequate resources, including the inability of management to devote sufficient time to the due diligence, negotiation and documentation of each proposed acquisition. Furthermore, even if we complete the acquisition of more than one target business at the same time, we may not be able to integrate the operations of such target businesses.

 

If we are unable to consummate a business combination within the allotted time periods set forth in this prospectus, we will implement a plan of stockholder approved dissolution and liquidation which will include the distribution of the proceeds of the Trust Account to our public stockholders.

 

Our offices are located at 2929 Arch Street, Suite 1703, Philadelphia, Pennsylvania 19104, and our telephone number is (215) 701-9555.

 

Management

 

Our company draws together four senior executives from the insurance and financial services industries:

 

Daniel G. Cohen, our Chairman, is Chairman of the Board of Directors of The Bancorp, Inc. (NASDAQ:TBBK), a publicly-held bank holding company, and is also chairman of the board of, and has acted in several senior management capacities with, Cohen Brothers, LLC, a diversified financial services company with approximately $10 billion in assets under management which specializes in the financing of small and mid-sized companies through issuances of collateralized debt obligations, or CDOs. Cohen Brothers, LLC is affiliated with our Sponsor.

 

Thomas H. Friedberg, our President and Chief Executive Officer, has 43 years of experience in the insurance industry, including serving as the chief executive officer of several small and medium-size specialty insurance companies, both private and publicly-traded, for 18 years, most recently as the President and Chief Executive Officer of Stonington Insurance Company.

 

Paul Vernhes, our Chief Financial Officer, was the Chief Financial Officer and Chief Accounting Officer of Compagnie de Réassurance d’Ile de France, a French reinsurance company.

 

David Nathaniel, our Chief Investment Officer and Secretary, has worked for Menorah, one of the largest insurance companies in Israel, serving as Chief Investment Officer of its pension fund, Mivtachim Pension Funds, the largest pension fund in Israel with over $3 billion in assets under management.

 

Private Placement

 

Our Sponsor has agreed to purchase an aggregate of 250,000 units from us no less than two days before the effectiveness of the registration statement of which this prospectus forms a part for a total purchase price of $2,500,000, or $10.00 per unit, in a private placement. No underwriting discounts and commissions or placement fees will be payable on the units sold in the private placement. If we do not complete this offering, we will return the funds raised in the private placement to our Sponsor. Our Sponsor and our officers and directors will not have any redemption rights or rights to any liquidation distributions with respect to the shares included in the private placement units if we do not complete a business combination.

 

Our Sponsor and our officers and directors have agreed to vote the 2,487,500 shares that they acquired from us at the time of our formation with the majority of the shares voted by our public stockholders when we submit our initial proposed business combination to our stockholders for their approval. Shares included in the units acquired by our Sponsor in the private placement, and any shares acquired by our Sponsor or our officers and directors in this offering or in the secondary market, will be voted in favor of any business combination

 

2


Table of Contents

proposed by our board of directors. With limited exceptions, the shares and warrants comprising units purchased in the private placement may not be sold, assigned or transferred until we consummate a business combination and the 2,487,500 shares acquired by our Sponsor and our officers and directors at the time of our formation may not be sold until six months after we complete a business combination.

 

Incentive Warrants

 

Before the closing of our private placement, we will issue to our Sponsor an aggregate of 946,667 warrants and will issue an aggregate of 473,333 warrants to several of our officers and directors, each to purchase our common stock, which we refer to as the incentive warrants. 710,000 incentive warrants will be exercisable for $8.00 per share beginning three months after we complete a business combination if the closing price of our common stock equals or exceeds $11.00 per share for at least 20 out of any 30 consecutive trading days preceding the date of exercise. The other 710,000 incentive warrants will be exercisable for $8.00 per share beginning three months after a business combination if the closing price of our common stock equals or exceeds $12.00 per share for at least 20 out of any 30 consecutive trading days preceding the date of exercise. Holders of the incentive warrants are entitled to exercise the incentive warrants by payment in cash of the exercise price or on a “cashless basis.” Exercises on a cashless basis enable the holder to convert the value in the warrant (the fair market value of the common stock minus the exercise price of the warrant) into shares of common stock. The warrants will expire at 5:00 p.m., New York City time, on [                    ], 2011 [five years from the date of this prospectus].

 

Sponsor Loan and Letter of Credit

 

Our Sponsor has loaned us $300,000, which we used to pay a portion of the expenses of this offering. We will repay this loan without interest from the proceeds of this offering.

 

Our Sponsor has agreed that, immediately preceding the closing of this offering, it will deliver an irrevocable letter of credit in the principal amount of $3,000,000 ($3,291,000 if the overallotment is exercised in full) issued by Commerce Bank to be held by American Stock Transfer & Trust Company as trustee for the benefit of the Trust Account. The fees charged by Commerce Bank in connection with the issuance of the letter of credit and all periodic and other fees related to the letter of credit, will be paid by our Sponsor and we will reimburse the Sponsor for these fees from amounts we are permitted to draw as working capital from the interest earned on the Trust Account. All amounts, if any, drawn under the letter of credit will be payable by our Sponsor and will not be reimbursed by us. This letter of credit will be drawn upon only if:

 

  Ÿ   we do not complete a business combination within the time set forth in this prospectus and must liquidate the Trust Account in accordance with its terms; and

 

  Ÿ   the amount in the Trust Account available for distribution to the public stockholders upon our liquidation is less than $10.00 per share.

 

Interest (after taxes payable) earned on funds in the Trust Account, after payment to us of up to $2,500,000 for working capital needs, will be retained in the Trust Account. From and after the date when the amount in the Trust Account, including the amount of deferred underwriting compensation and applying the amount of our Sponsor’s letter of credit, is equal to $97,000,000 (111,550,000 if the underwriters’ overallotment option has been exercised in full), or $10.00 per share held by public stockholders, interest earned on the funds in the Trust Account also may be used by us at our Sponsor’s option to reduce, on a dollar for dollar basis, the principal amount of our Sponsor’s letter of credit. We may use working capital derived from interest on amounts in the Trust Account to, among other things, make a deposit or down payment in connection with a proposed business combination, or as consideration for a “no shop” agreement with a target business. If the business combination were not completed, these payments could possibly be forfeited, leaving us with insufficient working capital to identify or complete another business combination without obtaining additional financing.

 

3


Table of Contents

The Offering

 

Merrill Lynch, Pierce, Fenner & Smith Incorporated, which we refer to as Merrill Lynch, and Maxim Group LLC, which we refer to as Maxim Group, are acting as the representatives of the underwriters of this offering.

 

Securities offered:

  

9,700,000 units, each unit consisting of:

    

Ÿ one share of common stock; and

    

Ÿ one warrant.

Common stock:

    

Number of shares outstanding before this offering and the private placement

  

2,487,500 shares

Number of shares to be outstanding after completion of this offering and the private placement

  



12,437,500 shares

Public Warrants:

    

Number of public warrants outstanding before this offering and the private placement

  

None

Number of public warrants (those included in units to be sold in this offering) outstanding after completion of this offering and the private placement

  





9,700,000

Exercisability

   Each warrant is exercisable for one share of common stock.

Exercise price

  

$8.00

Exercise period

   The public warrants will become exercisable on the later of:
    

Ÿ the completion of a business combination; or

    

Ÿ [                    ], 2007 [one year from the date of this prospectus].

     The public warrants will expire at 5:00 p.m., New York City time, on [                    ], 2010 [four years from the date of this prospectus] or earlier upon redemption.

Redemption

   We may redeem the public warrants:
    

Ÿ in whole and not in part;

 

Ÿ at a redemption price of $0.01 per warrant at any time after the warrants become exercisable;

 

Ÿ upon a minimum of 30 days’ prior written notice of redemption; and

 

4


Table of Contents
    

Ÿ if, and only if, the closing price of our common stock equals or exceeds $14.25 per share for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption.

     We have established the above criteria to provide public warrant holders with: (i) adequate notice of redemption to enable them to exercise their warrants, should they choose to do so and (ii) a sufficient differential between the then prevailing common stock price and the public warrant exercise price so there is a reasonable cushion to absorb a negative market reaction, if any, to our redemption call.
     If the foregoing conditions are satisfied and we call the public warrants for redemption, each warrant holder will be entitled to exercise his or her warrant before the date scheduled for redemption; however, we cannot assure you that the price of the common stock will exceed the call trigger price or the warrant exercise price after we make the redemption call.

Private Placement Warrants:

    

Number of private placement warrants outstanding before this offering and the private placement

  

None

Number of private placement warrants (those included in units to be sold to our Sponsor in the private placement) outstanding after completion of this offering and the private placement

  





250,000

Exercisability

   Each warrant is exercisable for one share of common stock.

Exercise price

   $8.00

Exercise period

   The 250,000 private placement warrants will become exercisable on the later of:
    

Ÿ the completion of a business combination; or

    

Ÿ [                    ], 2007 [one year from the date of this prospectus].

     The private placement warrants will expire at 5:00 p.m., New York City time, on [                    ], 2010 [four years from the date of this prospectus].

Redemption

   We may redeem the private placement warrants:
    

Ÿ in whole and not in part;

    

Ÿ at a redemption price of $0.01 per warrant at any time after the warrants become exercisable;

 

5


Table of Contents
    

Ÿ upon a minimum of 30 days’ prior written notice of redemption; and

    

Ÿ if, and only if, the closing price of our common stock equals or exceeds $14.25 per share for any 20 trading days within a 30-trading day period [ending three business days before we send the notice of redemption].

     If the foregoing conditions are satisfied and we call the private placement warrants for redemption, each warrant holder will be entitled to exercise his or her warrant before the date scheduled for redemption.

Incentive warrants:

    

Number of incentive warrants outstanding before this offering and the private placement

   1,420,000

Number of incentive warrants outstanding after completion of this offering and the private placement

   1,420,000

Exercisability

   Each incentive warrant is exercisable for one share of common stock.

Exercise price

   $8.00. Incentive warrants may be exercised on a cashless basis at the option of the holder.

Exercise period

   710,000 incentive warrants will be exercisable beginning three months after a business combination if, and only if, the closing price of our common stock equals or exceeds $11.00 per share for at least 20 trading days within any 30-trading day period preceding the date of exercise. The additional 710,000 incentive warrants will be exercisable beginning three months after a business combination if, and only if, the closing price of our common stock equals or exceeds $12.00 per share for at least 20 trading days within any 30-trading day period preceding the date of exercise.
     The incentive warrants will expire at 5:00 p.m., New York City time, on [                    ], 2011 [five years from the date of this prospectus].

Redemption

   None.

 

6


Table of Contents

Separation of securities underlying units:

   The units will separate into common stock and warrants 90 days after the date of this prospectus. Merrill Lynch and Maxim Group may decide to allow continued trading of the common stock and warrants as units following such separation. Merrill Lynch or Maxim Group will not permit separate trading of the common stock and warrants until:
    

Ÿ we have filed an audited balance sheet reflecting our receipt of the gross proceeds, before expenses, of this offering,

    

Ÿ we have filed a Current Report on Form 8-K and issued a press release announcing when such separate trading will begin, and

    

Ÿ the business day following the earlier to occur of the expiration of the underwriters’ overallotment option and its exercise in full.

     We expect to file the audited balance sheet referred to above promptly following the completion of this offering, and will, unless the overallotment option is exercised in full at the closing of this offering, file a new audited balance sheet promptly after expiration of the overallotment option exercise period if any portion of the overallotment option remains unexercised, or earlier following the exercise of the overallotment option in full.

Payments to Insiders:

   We have agreed to pay a monthly fee of $7,500 to Cohen Brothers, LLC, an affiliate of our Sponsor, for general and administrative services, including but not limited to, rent of offices, receptionist, secretarial and general office services. This agreement will commence as of the closing of this offering and will continue until the earlier of the consummation of a business combination or our dissolution and the liquidation of the Trust Account pursuant to our plan of dissolution and liquidation.
     None of our officers or directors or those of our Sponsor will receive any compensation in this offering; however, they will be entitled to reimbursement for reasonable out-of-pocket expenses incurred by them or their affiliates on our behalf, including expenses incurred by them with respect to the identification of a suitable business combination.
     Our Sponsor has loaned us $300,000 which we used to pay a portion of the expenses of this offering. This loan is without interest and will be repaid solely from the proceeds of this offering.

 

7


Table of Contents

Proposed American Stock Exchange Symbols:

   Units:                    [            ]
     Common stock:    [            ]
     Warrants:              [            ]

Proceeds to be held in Trust Account:

   $97,000,000 ($111,550,000 if the underwriters’ overallotment option is exercised in full), or $10.00 per unit, consisting of the proceeds from this offering, the proceeds of the private placement, and our Sponsor’s letter of credit for $3,000,000 ($3,291,000 if the overallotment option is exercised in full). The cash portion of these amounts will be placed in the Trust Account at Deustche Bank Trust Company Americas maintained by American Stock Transfer & Trust Company and the amount of our Sponsor’s letter of credit will, to the extent required, be drawable by American Stock Transfer & Trust Company for the benefit of the public stockholders, in each case pursuant to an agreement to be signed on the date of this prospectus. Of this amount, up to $92,060,000 ($105,737,000 if the underwriters’ overallotment option is exercised in full) may be used by us for the purpose of effecting a business combination, up to $1,940,000 ($2,522,000 if the underwriters’ overallotment option is exercised in full) will be paid to Merrill Lynch and Maxim Group if we complete a business combination, but will be forfeited by Merrill Lynch and Maxim Group if we do not complete a business combination. These funds will not be released until the earlier of the completion of a business combination or the implementation of our stockholder approved plan of dissolution and liquidation and the distribution of the Trust Account to our public stockholders; provided, however, that an aggregate of up to $2,500,000 of the interest earned on the Trust Account will be released to us to fund our working capital requirements (including, if necessary, the costs of our dissolution and liquidation) and we will be permitted to draw amounts necessary to pay taxes on earned interest.
     Except as provided below, unless and until a business combination is consummated, the funds held in the Trust Account (other than interest used to fund working capital) will not be available for our use for any expenses related to this offering or expenses which we may incur related to the investigation and selection of a target business and the negotiation of an agreement to acquire a target business.

 

8


Table of Contents
     The $1,940,000 ($2,522,000 if the underwriters’ overallotment option is exercised in full) of the funds
     attributable to deferred underwriting discount and commission in connection with this offering (and accrued interest thereon, net of taxes payable) will be released to Merrill Lynch and Maxim Group, respectively, and any stockholders exercising their redemption rights, upon completion of a business combination on the terms described in this prospectus, or to our public stockholders upon the implementation of a stockholder approved plan of dissolution and liquidation and the distribution of the Trust Account, but will in no event be available for use by us in a business combination.
     The expenses that we may incur before we complete a business combination may only be paid from funds not held in the Trust Account and any interest earned on funds in the Trust Account and released to us as described above. There will be no fees, reimbursements or cash payments to our existing stockholders and/or officers and directors other than:
    

Ÿ repayment of a $300,000 loan with no interest made by our Sponsor to cover certain offering expenses;

    

Ÿ reduction, on a dollar for dollar basis, of the total amount of the obligation of our Sponsor’s letter of credit through retention of interest earned on funds in the Trust Account;

    

Ÿ reimbursement of fees payable by our Sponsor with respect to the creation and maintenance of the letter of credit; and

    

Ÿ reimbursement for any expenses incident to the offering and finding a suitable business combination.

     The trust agreement governing the Trust Account provides that, in the event that our board of directors approves a plan of dissolution and liquidation and, at that time, we have insufficient funds outside of the Trust Account to pay for our dissolution and liquidation expenses, we may withdraw up to $100,000 from the Trust Account to pay for such expenses.
     None of the warrants or incentive warrants may be exercised until after the completion of a business combination and, thus, after the proceeds of the Trust Account have been disbursed. Accordingly, the warrant exercise price will be paid directly to us and not placed in the Trust Account.

 

9


Table of Contents

Stockholders must approve business combination:

   We will seek stockholder approval before we effect our initial business combination, even if we are not
     required to do so by applicable law. Except for units purchased in the private placement, our Sponsor and our officers and directors have agreed to vote shares that they own on the date of this prospectus in accordance with the majority of the shares voted by our public stockholders. Any shares acquired by our Sponsor in the private placement, or by our Sponsor or any of our officers or directors, in this offering or in the secondary market will be voted in favor of any business combination proposed by our board of directors.
     We will proceed with our initial business combination only if:
    

Ÿ a majority of the shares of common stock voted by the public stockholders are voted in favor of the business combination; and

    

Ÿ the number of shares owned by public stockholders who vote against the business combination and exercise their redemption rights as described below is less than 30% of the total number of shares sold in the offering and the private placement.

 

Voting against the business combination alone will not result in redemption of a stockholder’s shares. Such stockholder must also complete the procedure for exercising the redemption rights described below.

     If we seek approval from our stockholders to consummate a business combination within 90 days of the expiration of the 24 month period beginning on the date of the consummation of this offering (assuming that the period in which we need to consummate a business combination has been extended as provided in our amended and restated certificate of incorporation), the proxy statement related to such business combination will also seek stockholder approval for our board’s recommended plan of dissolution and liquidation in the event our stockholders do not approve such business combination.

Redemption rights for stockholders voting to
reject our initial business combination:

  

Public stockholders voting against a business combination will be entitled, if we complete it as our initial business combination, to redeem their common stock for $10.00 per share payable out of the Trust Account, plus any interest earned on their portion of the Trust Account (net of taxes payable), excluding:
    

Ÿ Trust Account interest previously used to fund our working capital needs and expenses,

 

10


Table of Contents
    

including the expenses associated with the pursuit of a business combination, up to a maximum of $2,500,000;

    

ŸTrust Account interest previously credited to the Trust Account and used to reduce, on a dollar for dollar basis, the principal amount of our Sponsor’s letter of credit; and

    

ŸTrust Account interest earned on the underwriters’ deferred compensation.

     Public stockholders who redeem their common stock for a share of the Trust Account will continue to have the right to exercise any warrants they may hold.

Plan of dissolution and liquidation if no
business combination:

  

Pursuant to the terms of the trust agreement by and between us and American Stock Transfer and Trust Company and the applicable provisions of the Delaware General Corporation Law, we will promptly dissolve, liquidate and distribute all funds held in the Trust Account to our public stockholders as part of a stockholder approved plan of dissolution and liquidation if we do not effect a business combination within 18 months after consummation of this offering (or within 24 months from the consummation of this offering if a letter of intent or definitive agreement has been executed within 18 months after consummation of this offering and the business combination contemplated by such letter of intent or definitive agreement has not yet been consummated within such 24 month period). Pursuant to our amended and restated certificate of incorporation, upon the expiration of such time periods, our purpose and powers will be limited to dissolving, liquidating and winding up. Also contained in our amended and restated certificate of incorporation is the requirement that we dissolve our company upon the expiration of such time periods. Consistent with such obligations and Delaware law, we will seek stockholder approval for any such plan of dissolution and liquidation, and our Sponsor and directors and executive officers have agreed to vote in favor of such dissolution and liquidation.
     As soon as is reasonably practicable upon the approval by our stockholders of our plan of dissolution and liquidation, we will distribute all funds held in the Trust Account to our public stockholders and pay, or reserve for payment in accordance therewith, from funds not held in trust,

 

11


Table of Contents
     our liabilities and obligations. Our Sponsor and all of our officers and directors who own common stock in our company have waived their right to receive distributions (other than with respect to common stock, or any shares of common stock underlying units, they purchase in this offering or in the after market) upon the liquidation of the Trust Account, as part of any plan of dissolution and liquidation.
     In addition, if we seek approval from our stockholders to consummate a business combination within 90 days of the expiration of the 24 month period beginning on the date of consummation of this offering (assuming that the period in which we need to consummate a business combination has been extended, as provided in our amended and restated certificate of incorporation), the proxy statement related to such business combination will also seek stockholder approval for our board’s recommended plan of dissolution and liquidation, in the event our stockholders do not approve such business combination. If no proxy statement seeking the approval of our stockholders for a business combination has been filed 30 days prior to the date which is 24 months from the date of this offering, our board will, as of such date, convene, adopt and recommend to our stockholders a plan of dissolution and liquidation, and, within 5 business days of such recommendation, will file a proxy statement with the Securities and Exchange Commission, or SEC, seeking stockholder approval for such plan.
    

We expect that the costs associated with the implementation and completion of a plan of dissolution and liquidation will be paid with funds held outside of the Trust Account, although we cannot assure you that we will have enough of such funds to achieve that purpose. If we do not have sufficient funds remaining outside of the Trust Account at the time our board of directors approves a plan of dissolution and liquidation, we will be permitted to draw up to a maximum of $100,000 of funds held in the Trust Account to implement and complete the stockholder approved plan of dissolution and liquidation.

 

We currently anticipate the costs of our dissolution and liquidation to be between $50,000 and $75,000 and to include all costs and expenses relating to: (i) preparing and mailing our proxy statement for a stockholders’ meeting relating to approval of our plan of dissolution and liquidation, (ii) the costs of conducting such meeting, (iii) the winding up of our

 

12


Table of Contents
     affairs (including contacting third parties payees) and (iv) preparing and filing our dissolution documentation in the State of Delaware.
     In order to protect the amounts held in the Trust Account, our Sponsor has agreed to indemnify us for claims of creditors that have not executed a valid and binding waiver of their right to seek payment of amounts due to them out of the Trust Account, provided and to the extent that (with the approval of our Chief Executive Officer and the vote or written consent of no less than a majority of our board of directors, including all of our non-independent directors) we have elected to forego obtaining valid and enforceable waivers from such creditors. Cohen Brothers, LLC, the parent of our Sponsor, has separately agreed with our Sponsor to provide our Sponsor with any funds required to meet these indemnification obligations.
    

In the event we seek stockholder approval for a plan of dissolution and liquidation and do not obtain such

ap